Evaluating the Performance of Ultrasound Screening for Congenital Heart Disease: A Descriptive Cohort Study

Abstract

Objective The objective of this study was to evaluate the rate of abnormal fetal echocardiogram after normal detailed anatomy ultrasound when both are performed by maternal–fetal medicine specialists.

Study Design Retrospective review of women who underwent detailed anatomy ultrasound and fetal echocardiography between 16 and 26 weeks' gestation at a single center. Women included had at least one indication for fetal echocardiography as recommended by the American Institute of Ultrasound in Medicine and normal cardiac anatomy on initial detailed anatomy ultrasound. Women with previous abnormal ultrasound, extracardiac anomalies, and abnormal or incomplete cardiac anatomy on initial examinations were excluded. The primary outcome was abnormal fetal echocardiogram, defined as a structural cardiac anomaly.

Results A total of 1,000 women (1,052 fetuses) were included. The most common indication for echocardiography was family history of congenital heart disease. Five fetuses had an abnormal echocardiogram (0.5%, 95% confidence interval: 0.2–1.1%), only one of which altered care. The other four were suspected ventricular septal defects; of these, three were not seen on postnatal cardiac imaging.

Conclusion The rate of abnormal fetal echocardiogram after a normal detailed anatomy ultrasound interpreted by maternal–fetal medicine specialists is low. Fetal echocardiography as a second screening test is of low clinical utility and unlikely to be cost-effective in this setting.

Keywords

congenital heart disease - CHD - fetal anatomy ultrasound - fetal echocardiography

• References

• 1 van der Linde D, Konings EE, Slager MA. , et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011; 58 (21) 2241-2247
• 2 American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med 2013; 32 (06) 1067-1082
• 3 Liu H, Zhou J, Feng QL. , et al. Fetal echocardiography for congenital heart disease diagnosis: a meta-analysis, power analysis and missing data analysis. Eur J Prev Cardiol 2015; 22 (12) 1531-1547
• 4 Rosano A, Botto LD, Botting B, Mastroiacovo P. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J Epidemiol Community Health 2000; 54 (09) 660-666
• 5 Killen SA, Mouledoux JH, Kavanaugh-McHugh A. Pediatric prenatal diagnosis of congenital heart disease. Curr Opin Pediatr 2014; 26 (05) 536-545
• 6 Friedman AM, Phoon CK, Fishman S, Seubert DE, Timor-Tritsch IE, Schwartz N. The utility of fetal echocardiography after an unremarkable anatomy scan. Obstet Gynecol 2011; 118 (04) 921-927
• 7 Rychik J, Ayres N, Cuneo B. , et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 2004; 17 (07) 803-810
• 8 Allan LD, Crawford DC, Chita SK, Anderson RH, Tynan MJ. Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am J Cardiol 1986; 58 (03) 334-337
• 9 Starikov R, Bohrer J, Goh W. , et al. Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus. Pediatr Cardiol 2013; 34 (07) 1716-1722
• 10 Perri T, Cohen-Sacher B, Hod M, Berant M, Meizner I, Bar J. Risk factors for cardiac malformations detected by fetal echocardiography in a tertiary center. J Matern Fetal Neonatal Med 2005; 17 (02) 123-128
• 11 Starikov RS, Bsat FA, Knee AB, Tsirka AE, Paris Y, Markenson GR. Utility of fetal echocardiography after normal cardiac imaging findings on detailed fetal anatomic ultrasonography. J Ultrasound Med 2009; 28 (05) 603-608
• 12 American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med 2013; 32 (06) 1083-1101
• 13 Carvalho JS, Allan LD, Chaoui R. , et al; International Society of Ultrasound in Obstetrics and Gynecology. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 2013; 41 (03) 348-359
• 14 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 101: Ultrasonography in pregnancy. Obstet Gynecol 2009; 113 (2 Pt 1): 451-461
• 15 Sekhavat S, Kishore N, Levine JC. Screening fetal echocardiography in diabetic mothers with normal findings on detailed anatomic survey. Ultrasound Obstet Gynecol 2010; 35 (02) 178-182
• 16 Muller PR, James A, Feldman K, Herlong JR. Utility of fetal echocardiogram in high-risk patients. Aust N Z J Obstet Gynaecol 2005; 45 (02) 117-121
• 17 Pinto NM, Nelson R, Puchalski M, Metz TD, Smith KJ. Cost-effectiveness of prenatal screening strategies for congenital heart disease. Ultrasound Obstet Gynecol 2014; 44 (01) 50-57
• 18 Wax J, Minkoff H, Johnson A. , et al. Consensus report on the detailed fetal anatomic ultrasound examination: indications, components, and qualifications. J Ultrasound Med 2014; 33 (02) 189-195